Skip to main navigation Skip to main content Skip to footer For Medicare For Providers For Brokers For Employers Español For Individuals & Families: For Individuals & Families Medical Dental Other Supplemental Explore coverage through work How to Buy Health Insurance Types of Dental Insurance Open Enrollment vs. Special Enrollment See all topics Shop for Medicare plans Member Guide Find a Doctor Log in to myCigna
Home Knowledge Center Wellness Library cilgavimab and tixagevimab

cilgavimab and tixagevimab

Brand: Evusheld

What is the most important information I should know about cilgavimab and tixagevimab?

What is the most important information I should know about cilgavimab and tixagevimab?

The US Food and Drug Administration (FDA) has authorized emergency use of cilgavimab in combination with another medicine called tixagevimab for the prevention before exposure of COVID-19 in adults and people 12 years of age and older (weighing at least 40 kg or 88 lbs).

Cilgavimab and tixagevimab have not been approved to treat coronavirus or COVID-19.

What is cilgavimab and tixagevimab?

What is cilgavimab and tixagevimab?

Cilgavimab in combination with tixagevimab is an experimental medicine being studied for the prevention before exposure of COVID-19. It is not yet known if this medicine is safe and effective.

The US Food and Drug Administration (FDA) has authorized emergency use of cilgavimab in combination with another medicine called tixagevimab for the prevention before exposure of COVID-19 in adults and people 12 years of age and older (weighing at least 40 kg or 88 lbs) who are not currently infected with COVID-19 and:

  • who have not had a known recent exposure to someone infected with COVID-19;
  • who are moderately to severely immunocompromised and may not get an adequate immune response to COVID-19 vaccination; or
  • for whom vaccination with any COVID-19 vaccine is not recommended due to a history of severe adverse reaction to a COVID-19 vaccine.

Cilgavimab and tixagevimab is not authorized for use in people:

  • for treatment of COVID-19; or
  • for prevention after exposure of COVID-19 in people who have been exposed to someone infected with COVID-19.

Cilgavimab and tixagevimab is not a substitute for vaccination in people for whom COVID-19 vaccine is recommended. People who may benefit from COVID-19 vaccination should get vaccinated.

In people who have received a COVID-19 vaccine, cilgavimab and tixagevimab should be given at least 2 weeks after vaccination.

Cilgavimab and tixagevimab may also be used for purposes not listed in this medication guide.

What should I discuss with my healthcare provider before receiving cilgavimab and tixagevimab?

What should I discuss with my healthcare provider before receiving cilgavimab and tixagevimab?

You should not use cilgavimab and tixagevimab if you are allergic to it.

Tell your doctor if:

  • you had a COVID-19 vaccine;
  • you have heart problems;
  • you have a coagulation disorder or thrombocytopenia (low levels of platelets in the blood);
  • you are pregnant or breastfeeding; or
  • you have any serious or chronic disease.

COVID-19 is more likely to cause serious illness or death in a pregnant woman. Not all risks are known yet, but being treated with cilgavimab and tixagevimab is likely to be less harmful than being infected with COVID-19 during pregnancy.

How are cilgavimab and tixagevimab given?

How are cilgavimab and tixagevimab given?

Cilgavimab and tixagevimab are injected into a muscle by a healthcare provider as two separate consecutive injections.

Cilgavimab and tixagevimab can be given after 6 months of the initial consecutive injections. Follow your doctor's instructions about receiving a repeat dose if needed.

You will be watched for at least 1 hour to make sure you do not have an allergic reaction.

Being treated with cilgavimab and tixagevimab will not make you less contagious to other people. Keep using infection control methods such as self-isolation, social distancing, hand-washing, using protective face covering, disinfecting surfaces you touch a lot, and not sharing personal items with others.

Cilgavimab and tixagevimab are still being studied and all of the risks are not yet known.

What happens if I miss a dose?

What happens if I miss a dose?

Cilgavimab is given with tixagevimab in two separate consecutive injections and does not have a daily dosing schedule.

What happens if I overdose?

What happens if I overdose?

In a medical setting an overdose would be treated quickly.

What should I avoid while receiving cilgavimab and tixagevimab?

What should I avoid while receiving cilgavimab and tixagevimab?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

What are the possible side effects of cilgavimab and tixagevimab?

What are the possible side effects of cilgavimab and tixagevimab?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your medical caregivers right away if you have:

  • throat irritation, swelling in your face or throat;
  • dizziness, a light-headed feeling (like you might pass out);
  • chest pain, wheezing, shortness of breath;
  • fever, chills, sweating, nausea;
  • fast or slow heartbeats, headache, pounding in your neck or ears;
  • weakness, tiredness;
  • a rash or itching; or
  • muscle pain.

Call your doctor if you have new or worsening symptoms after the injection, such as fever, confusion, weakness, tiredness, trouble breathing, or fast or slow heartbeats.

Common side effects may include:

  • headache;
  • tiredness; or
  • cough.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect cilgavimab and tixagevimab?

What other drugs will affect cilgavimab and tixagevimab?

Other drugs may affect cilgavimab and tixagevimab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Where can I get more information?

Where can I get more information?

Your doctor or pharmacist can provide more information about cilgavimab and tixagevimab.

This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card File a claim View my claims and EOBs Check coverage under my plan See prescription drug list Find an in-network doctor, dentist, or facility Find a form Find 1095-B tax form information View the Cigna Glossary Contact Cigna

Audiences

Individuals and Families Medicare Employers Brokers Providers

Secure Member Sites

myCigna member portal Health Care Provider portal Cigna for Employers Client Resource Portal Cigna for Brokers

Cigna Company Information

About Cigna Company Profile Careers Newsroom Investors Suppliers Third Party Administrators International Evernorth

 Cigna. All rights reserved.

Privacy Legal Product Disclosures Cigna Company Names Customer Rights Accessibility Non-Discrimination Notice [PDF] Language Assistance [PDF] Report Fraud Sitemap

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., and Cigna HealthCare of North Carolina, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities  that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details